Dr. Knollmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2215B 21st Ave S
Nashville, TN 37232- Is this information wrong?
Education & Training
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1993 - 1995
University of Cincinnati College of MedicineClass of 1993
Certifications & Licensure
TN State Medical License 2005 - 2025
DC State Medical License 1997 - 2006
VA State Medical License 1994 - 2004
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Clinical Trials
- Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia Start of enrollment: 2011 Dec 01
- New Formulations of Propafenone to Treat Atrial Fibrillation Start of enrollment: 2016 Oct 01
Publications & Presentations
PubMed
- 1 citationsHypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors.Paul J M Wijnker, Rafeeh Dinani, Nico C van der Laan, Sila Algül, Bjorn C Knollmann, Arie O Verkerk, Carol Ann Remme, Coert J Zuurbier, Diederik W D Kuster, Jolanda va...> ;Cardiovascular Research. 2024 Mar 14
- -Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic inMice.Gochman, A., Do, T., Kim, K., Schwarz, J., Thorpe, M., Blackwell, D., Smith, A., Rebbeck, R., Akers, W., Cornea, R., Laver, D., Johnston, J., Knollmann, B., Ritschel, P.> ;Molecular Pharmacology. 2024 Feb 15
- 1 citationsRyanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts.Joshi, P., Estes, S., Dey, S., DeMazumder, D., Knollmann, B.> ;Elife. 2023 Dec 11
- Join now to see all
Journal Articles
- Unnatural Verticilide Enantiomer Inhibits Type 2 Ryanodine Receptor-Mediated Calcium Leak and Is AntiarrhythmicBjorn Knollmann, MD, Proceedings of the National Academy of Sciences
Press Mentions
VUMC Joins Research Network to Fight Atrial FibrillationJune 14th, 2018- Six Vanderbilt Physicians Honored by Medical SocietiesMay 3rd, 2018
Meet the First AuthorsDecember 7th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
